Apr 29, 2020 / NTS GMT
Operator
Greetings, and welcome to the VolitionRx webcast. It is now my pleasure to introduce your host, Scott Powell, Head of Investor Relations and US CFO. Thank you, Mr. Powell. You may begin.
Scott Powell - VolitionRx Ltd - EVP, IR & CFO, Volition America, Inc.
Thank you, Doug, and welcome, everyone, to the VolitionRx Limited investor presentation. I hope you're all doing well in these different and challenging times. Thank you very much for joining me today to hear a bit more about the Volition story, and, for those of you who are familiar, to get an update on some of our current developments and upcoming milestones throughout the course of 2020 and 2021. So again, we're VolitionRx Limited, ticker VNRX on the NYSE American stock Exchange.
And I'd point you to this slide. I will be making some forward-looking statements during this presentation. This slide, easy to read. Our mission is simple: we want to save lives. What is Volition doing? We are a diagnostics company. We're developing blood tests primarily to screen for different cancer types. And I'll
VolitionRx Ltd. Webcast SNN Network Transcript
Apr 29, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers